HDII - Hypertension Diagnostics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5474.12k
Enterprise Value 31.68M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.83
Price/Book (mrq)N/A
Enterprise Value/Revenue 310.04
Enterprise Value/EBITDA 6-1.20

Trading Information

Stock Price History

Beta (3Y Monthly) -9.38
52-Week Change 3-70.00%
S&P500 52-Week Change 32.33%
52 Week High 30.0400
52 Week Low 30.0006
50-Day Moving Average 30.0066
200-Day Moving Average 30.0043

Share Statistics

Avg Vol (3 month) 36.51M
Avg Vol (10 day) 3915.48k
Shares Outstanding 552.39M
Float N/A
% Held by Insiders 10.00%
% Held by Institutions 10.07%
Shares Short (Apr 10, 2003) 4N/A
Short Ratio (Apr 10, 2003) 40.01
Short % of Float (Apr 10, 2003) 4N/A
Short % of Shares Outstanding (Apr 10, 2003) 40.00%
Shares Short (prior month Feb 11, 2003) 412.05k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2012
Most Recent Quarter (mrq)Mar 31, 2013

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-933.38%

Management Effectiveness

Return on Assets (ttm)-54.02%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)167.33k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)-111.85k
EBITDA -1.41M
Net Income Avi to Common (ttm)-1.94M
Diluted EPS (ttm)-0.0340
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.66k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.3M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.24
Book Value Per Share (mrq)-0.03

Cash Flow Statement

Operating Cash Flow (ttm)-424k
Levered Free Cash Flow (ttm)337.74k